Found: 5
Select item for more details and to access through your institution.
Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 12, p. 1093, doi. 10.1007/s40261-022-01210-1
- By:
- Publication type:
- Article
Prediction of in vitro metabolic stability of calcitriol analogs by QSAR.
- Published in:
- Journal of Computer-Aided Molecular Design, 2003, v. 17, n. 12, p. 849, doi. 10.1023/B:JCAM.0000021861.31978.da
- By:
- Publication type:
- Article
Correction to: Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 653, doi. 10.1007/s40262-023-01236-4
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 645, doi. 10.1007/s40262-023-01215-9
- By:
- Publication type:
- Article
Short- versus Long-Term, Gender and Species Differences in the Intestinotrophic Effects of Long-Acting Glucagon-Like Peptide 2 Analog.
- Published in:
- Physiological Research, 2022, v. 71, n. 2, p. 323, doi. 10.33549/physiolres.934839
- By:
- Publication type:
- Article